Protective effects of piperlongumine against adjuvant-induced arthritis in rats through modulating OPG/RANKL/NF-κB signaling pathway
Journal of Pharmacy and Pharmacology · 2024
DOI: 10.1093/jpp/rgae015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2024. Verfasst von Sheng-Dong Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, Anhui Provincial Corps Hospital of Chinese People's Armed Police Forces, Hefei, 230041 Anhui, China. Hauptthemen laut MEDLINE: Arthritis, Experimental, RANK Ligand, Signal Transduction, Osteoprotegerin. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Scientific Research Foundation, Natural Science Foundation.
Abstract (Originalsprache)
Objectives
We examined the antirheumatoid effects of piperlongumine (PLM) on rat adjuvant-induced arthritis (AIA) and explored the underlying mechanisms involved.
Methods
PLM (2.5, 5, and 10 mg/kg) was administered intraperitoneally to AIA rats to assess its effectiveness. Blood, thymus, spleen, ankle joint, and synovial tissue samples were gathered for subsequent analyses, like enzyme-linked immunosorbent assay, thymus/spleen index measurement, ankle joint pathological examination, immunohistochemistry assay, polymerase chain reaction, and western blot assay. Moreover, the involvement of osteoprotegerin (OPG)/receptor activators of nuclear factor κB ligand (RANKL)/nuclear factor-κB (NF-κB) signaling was investigated. Key findings PLM effectively relieved inflammation and joint destruction in AIA rats, as indicated by reductions in hind paw swelling, arthritis index, thymus/spleen index, ankle joint pathological damage, production of TNF-α, IL-1β, and IL-6 in both serum and synovium, and osteoclast formation. Also, PLM treatment raised OPG production, reduced RANKL expression, and elevated the OPG/RANKL ratio in synovial tissues. Furthermore, PLM prevented IκBα degradation and phosphorylation, resulting in a reduced expression of the nuclear NF-κB p65 protein in AIA rat synovial tissues.
Conclusions
PLM demonstrated strong antiarthritic effects in rats with AIA by influencing the OPG/RANKL/NF-κB signaling pathway, highlighting its potential clinical relevance in treating rheumatoid arthritis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecology and Obstetrics, Anhui Provincial Corps Hospital of Chinese People's Armed Police Forces, Hefei, 230041 Anhui, China.
- Department of Clinical Medicine, Clinical Medical College, Anhui Medical University, Hefei, 230032 Anhui, China.
- Department of Pathology, School of Basic Medicine, Anhui Medical University, Hefei, 230032 Anhui, China.
- Department of Medicinal Chemistry, School of Pharmacy, Anhui Medical University, Hefei, 230032 Anhui, China.
- Department of Biomedical Engineering, School of Information Science and Technology, University of Science and Technology of China, Hefei, 230026 Anhui, China.
ORCID-Profile: Li Cai
Förderung
- Scientific Research Foundation
- Natural Science Foundation
Zitieren
APA
Wu, S. D., Wu, X. J., Wang, T. T., Jiang, F., Hu, M. W., Li, R., Liu, J., & Cai, L. (2024). Protective effects of piperlongumine against adjuvant-induced arthritis in rats through modulating OPG/RANKL/NF-κB signaling pathway. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgae015
Vancouver
Wu SD, Wu XJ, Wang TT, Jiang F, Hu MW, Li R, et al. Protective effects of piperlongumine against adjuvant-induced arthritis in rats through modulating OPG/RANKL/NF-κB signaling pathway. Journal of Pharmacy and Pharmacology. 2024. doi:10.1093/jpp/rgae015
BibTeX
@article{Wu2024,
author = {Wu, Sheng-Dong and Wu, Xin-Jie and Wang, Tian-Tian and Jiang, Fei and Hu, Ming-Wang and Li, Rong and Liu, Ji and Cai, Li},
title = {Protective effects of piperlongumine against adjuvant-induced arthritis in rats through modulating OPG/RANKL/NF-κB signaling pathway},
journal = {Journal of Pharmacy and Pharmacology},
year = {2024},
doi = {10.1093/jpp/rgae015}
}
EUVIMED